Eric W. Dittmann
Paul Hastings LLPGeneral
Experience22 yrs
Elite Ratings
DCT
Practice Areas
Biotech (66 cases)
Chemical Biotech (17 cases)
Chemical (3 cases)
Comp. Arch. and Software (2 cases)
Communications (2 cases)
Ratings
Experience
Grade
Trend
DCT
L4
A
PTAB
L2
C
CAFC
L1
D
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00913 | Merus NV v. Xencor Inc | 08/05/24 | Challenger | |
| 1:24-CV-00095 | Advanced Accelerator Applications USA Inc v. Lantheus Medical Imaging Inc | 01/25/24 | ||
| 2:23-CV-00222 | CureVac Se v. BioNTech Se | 05/19/23 | Challenger | |
| 3:23-CV-01876 | Arbutus Pharma Corp v. Pfizer Inc | 04/04/23 | Challenger | |
| 1:22-CV-01359 | Inpria Corp v. Lam Research Corp | 10/14/22 | ||
| 1:22-CV-11378 | ModernaTX Inc v. Pfizer Inc | 08/26/22 | Challenger | |
| 1:22-CV-11202 | BioNTech Se v. CureVac AG | 07/25/22 | Challenger | |
| 3:22-CV-04635 | Helsinn Healthcare SA v. Gland Pharma Ltd | 07/18/22 | Patent Owner | |
| 1:21-CV-01478 | San Rocco Therap LLC v. Bluebird Bio Inc | 10/21/21 | ||
| 1:21-CV-01411 | Allergan Inc v. Revance Therap Inc | 10/01/21 |